Skip to content

Orbimed Advisors LLC, 10% owner at Enliven Therapeutics, sold ELVN on Jun 22, 2026

Data as of Oct 16

▼ SELL$2.1M46,776 shares at $45.00Orbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.
Watch ELVN
Traded
Jun 22, 2026
Disclosed
Jun 24, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Orbimed Advisors LLC, 10% owner at Enliven Therapeutics, sold ELVN on Jun 22, 2026TRADEDDISCLOSED
ELVNSimilar stocks (XLV — its sector index fund), rebased to ELVN's price on the disclosure day
ELVN since disclosure
−21.9%
after the sale
Similar stocks (XLV) since disclosure
+15.2%
XLV — its sector index fund

Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  2. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  3. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  4. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  5. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  6. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  7. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  8. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  9. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  10. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  11. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade

See every trade on ELVN →